Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC

High-throughput and Sensitive Size Exclusion Chromatography (SEC) of Biologics Using Agilent AdvanceBio SEC Columns Agilent AdvanceBio SEC 300 Å, 2.7 µm columns Application note Bio-Pharmaceutical Author Abstract M. Sundaram Palaniswamy Monoclonal antibody (mAb) aggregation can arise due to multiple mechanisms…

Agilent Biocolumns Aggregate/Fragment Analysis Application Compendium Contents Background 2 Getting Started 3 How to Guide - Size Exclusion Chromatography for Biomolecule Analysis - 5991-3651EN 4 Featured Application Notes Elevate Your mAb Aggregate Analysis - 5994-2709EN 1 22 22 High-Resolution, High-Throughput…

Quantitation of mAb and ADC Aggregation Using SEC and an Aqueous Mobile Phase The Agilent 1260 Infinity Bio-Inert Quaternary LC System and the AdvanceBio SEC 300Å, 2.7 µm Column Application Note Biologics and Biosimilars Author Abstract M.Sundaram Palaniswamy Size exclusion…

Comparison of Biosimilar and Innovator Monoclonal Antibody Rituximab Using the Agilent 1260 Infinity Bio-inert LC System and Agilent OpenLAB Match Compare Software Application Note Biotherapeutics & Biosimilars Authors Abstract M. Sundaram Palaniswamy and Rituximab is a chimeric mouse/human monoclonal antibody…